The current genitourinary fistula classification systems have poor to fair prognostic value, as does an empirically derived scoring system that predicts fistula closure 3 months after surgery, according to the findings of a new prospective cohort study.
Between 70 and 90 percent of women carrying a fetus diagnosed in utero with Down syndrome choose to abort. Is terminating a fetus diagnosed with Down syndrome the same as terminating a fetus because of its gender?
Monitoring uterine contractions with internal tocodynamometry (IT) versus external tocodynamometry (ET) results in similar maternal and neonatal outcomes in women whose labor is induced or augmented with oxytocin.
The use of APTIMA human papillomavirus (AHPV) assay for the detection of high-risk human papillomavirus E6/E7 oncogenic messenger RNA is an effective triage method for colposcopy referral in women with atypical squamous cells of undetermined significance cytology (ASC-US).
A study by Norwegian researchers has shown that the use of folic acid supplements around the time of conception may lower the risk of autism in children. The study was published in the February 13, 2013, issue of The Journal of the American Medical Association.
High intakes of calcium in women are associated with higher death rates from all causes and from cardiovascular disease, but not from stroke. This is the conclusion of a prospective longitudinal cohort study by researchers in Sweden.
On February 12, the Interagency Breast Cancer and Environmental Research Coordinating Committee (IBCERCC) released the report “Breast Cancer and the Environment: Prioritizing Prevention.” The report is a result of the Breast Cancer and Environmental Research Act, which was passed by Congress in October 2008. The act required the US Secretary of Health and Human Services (HHS) to establish the IBCERCC, composed of federal and nonfederal members, to examine the current state of breast cancer and the environment research and make recommendations for eliminating any knowledge gaps.
Preconception genetic carrier testing has become more widely available and affordable, but is not always routinely recommended by physicians. Do you encourage it among patients planning to conceive?
Women who have migraine with aura, especially those who take combined hormonal contraceptives (CHCs) have an increased risk for cardiovascular or thrombotic events.
A recap of social media updates from the 33rd Annual Meeting of the Society for Maternal and Fetal Medicine. #SMFM13
On January 18, 2013, the FDA announced its approval of onabotulinumtoxinA (Botox) for the treatment of overactive bladder in adults who cannot use or who do not respond adequately to anticholinergic medications.
Patients with pelvic girdle pain during pregnancy who had a cesarean section were more likely to experience persistent pain 6 months after delivery than patients who delivered vaginally, according to a new follow-up study from the Norwegian Institute of Public Health.
A new American College of Obstetricians and Gynecologists (ACOG) committee opinion (no. 554) addresses the detection and prevention of sexual coercion and violence within women’s relationships. The opinion was developed by the Committee on Health Care for Underserved Women.
A registry-based study by researchers at UC San Francisco (UCSF) has shown an association between BRCA1/2 mutations and early menopause. The findings, published in Cancer, suggest that women who carry the genetic defect may be at risk of earlier infertility.
Living alone or being unmarried not only increases the risk of having a heart attack, but results in a worse prognosis after a heart attack in both men and women, according to researchers in Finland. Conversely, they say, especially among middle-aged couples, being married and cohabiting are associated with "considerably better prognosis of acute cardiac events both before hospitalization and after reaching the hospital alive."
New drugs, new research, new guidelines… there’s a lot for ob/gyns to look forward to in the coming year. Here, the leaders of seven ob/gyn societies share the most interesting, important, exciting things on their radar for 2013.
From ASRM’s removal of the ‘experimental’ label from the procedure of oocyte cryopreservation, to discoveries into the complex genetic processes involved in ovarian cancer, 2012 was another important year in ob/gyn research. Here, the leaders of seven major ob/gyn societies reflect on the most exciting research of the last year.
An independent panel convened by the NIH has concluded that the name “polycystic ovary syndrome (PCOS)” causes confusion and is a barrier to progress in the realms of both research and effective patient care.
This middle aged lady had a history of pelvic pain. She was previously diagnosed with a suspected fibroid. What’s your diagnosis based on these uterine images?
Continuous infusion of the NSAID ketorolac, a powerful nonopioid analgesic, is a safe therapeutic option for the management of postoperative pain, concludes a double-blind randomized controlled trial.
The FDA recently approved oxybutynin transdermal (Oxytrol for Women) treatment for overactive bladder (OAB) in women aged 18 years and older. It is the first anticholinergic drug to be made available over the counter (OTC) for treatment of OAB, according to manufacturer Merck.
A 2-step immunotherapy and combination chemotherapy protocol is feasible for patients with advanced, recurrent ovarian cancer, according to the results of a small pilot study by University of Pennsylvania researchers. Published in OncoImmunology and supported by the National Cancer Institute, the report documented response in women whose tumors previously had failed to respond to bevacizumab and cyclophosphamide.
Rates of sexually transmitted infection (STI) are 7 times higher in women in the military than in those who are civilians. This alarming finding was published in an article that appeared in the November 2012 issue of the Journal of Women’s Health.
The symptoms of overactive bladder syndrome were most improved when patients used anticholinergic drugs either alone or in combination with bladder training exercises, according to the results of an intervention review and meta-analysis conducted by the Cochrane Incontinence Group.
What is your diagnosis based on these 3rd trimester fetal images?
Although many researchers have recommended cystoscopy as a universal screening tool to detect injury at the time of hysterectomy, new research recommends selective use of cystoscopy based on the low absolute risk of urinary tract injury.
Medicare spending on breast cancer screening exceeds $1 billion annually in the fee-for-service program, according to a recent study.
Looking at the legal issues surrounding a ruptured uterus, lack of a prompt diagnosis for placental abruption, uterine perforation during D&C, and what constitutes adequate fetal monitoring.
ACOG has recently updated their guidelines for preterm birth. One of the doctors on Contemporary OB/GYN's editorial board looks at what has changed in the past 12 years.
A look at why you need to determine whether twins are monochorionic or dichorionic.
